Neurofilament metabolism in sporadic amyotrophic lateral sclerosis

Journal of the Neurological Sciences

Volumn 169, Issue 1-2, 1999, Pages 170-177

  Strong, Michael J ^a  

^a ROBARTS RESEARCH INSTITUTE   (Canada)

Author keywords

Motor neuron disease; Neurofilament; Nitration; Nitric oxide synthase; Peroxynitrite

Indexed keywords

NEUROFILAMENT PROTEIN; NITRIC OXIDE SYNTHASE; PEROXYNITRITE; SUPEROXIDE DISMUTASE;

AMYOTROPHIC LATERAL SCLEROSIS; CELL METABOLISM; CERVICAL SPINAL CORD; HUMAN; MOTOR NEURON DISEASE; NERVE CELL DEGENERATION; NEUROFILAMENT; NITRATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PURIFICATION; REVIEW;

EID: 0032744516     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(99)00241-5     Document Type: Article

References (119)

1. Lawyer T., Netsky M.G. Amyotrophic lateral sclerosis. Arch. Neurol. 8:1963;117-127.
2. Brownell B., Oppenheimer D.R., Hughes J.T. The central nervous system in motor neurone disease. J. Neurol. Neurosurg. Psychiatry. 33:1970;338-357.
3. Hirano A. Cytopathology of amyotrophic lateral sclerosis. Rowland L.P. Amyotrophic lateral sclerosis and other motor neuron disorders. 1991;91-101 Raven Press, New York.
4. Hirano A., Kurland L.T., Sayre G.P. Familial amyotrophic lateral sclerosis. Arch. Neurol. 16:1967;232-242.
5. Takahashi H., Makifuchi T., Nakano R., Sato S., Inuzuka T., Sakimura K., Mishina M., Honma Y., Tsuji S., Ikuta F. Familial amyotrophic lateral sclerosis with a mutation in the Cu/Zn superoxide dismutase gene. Acta Neuropathol. 88:1994;185-188.
6. Ince P.G., Shaw P.J., Slade J.Y., Jones C., Hudgson P. Familial amyotrophic lateral sclerosis with a mutation in exon 4 of the Cu/Zn superoxide dismutase gene: pathological and immunocytochemical changes. Acta Neuropathol. 92:1996;395-403.
7. Rouleau G.A., Clark A.W., Rooke K., Pramatarova A., Krizus A., Suchowersky O., Julien J.-P., Figlewicz D. SOD1 mutation is associated with accumulation of neurofilaments in amyotrophic lateral sclerosis. Ann. Neurol. 39:1996;128-131.
8. Orrell R.W., King A.W., Hilton D.A., Campbell M.J., Lane R.J.M., de Belleroche J.S. Familial amyotrophic lateral sclerosis with a point mutation of SOD-1: intrafamilial heterogeneity of disease duration associated with neurofibrillary tangles. J. Neurol. Neurosurg. Psychiatry. 59:1995;266-270.
9. Rodgers-Johnson P., Garruto R.M., Yanigahara R., Chen K.M., Gajdusek D.C., Gibbs C.J. Jr. Amyotrophic lateral sclerosis and parkinsonism-dementia on Guam: a 30-year evaluation of clinical and neuropathological trends. Neurology. 36:1986;7-13.
10. Figlewicz D.A., Garruto R.M., Krizus A., Yanagihara R., Rouleau G.A. The Cu/Zn superoxide dismutase gene in ALS and Parkinsonism-dementia of Guam. NeuroReport. 5:1994;557-560.
11. Strong M.J., Grace G.M., Orange J.B., Leeper H.A. Cognition, language and speech in amyotrophic lateral sclerosis: a review. J. Clin. Exp. Neuropsychol. 18:1996;291-303.
12. Strong M.J., Grace G.M. Cognitive changes in amyotrophic lateral sclerosis. Kertesz A., Munoz D.A. Pick's disease and pick complex. 1998;Wiley, New York.
13. Carpenter S. Proximal axonal enlargement in motor neuron disease. Neurology. 18:1968;841-851.
14. Averback P. Unusual particles in motor neuron disease. Arch. Pathol. Lab. Med. 105:1981;490-493.
15. Delisle M.B., Carpenter S. Neurofibrillary axonal swellings and amyotrophic lateral sclerosis. J. Neurol. Sci. 63:1984;241-250.
16. Manetto V., Sternberger N.H., Perry G., Sternberger L.A., Gambetti P. Phosphorylation of neurofilaments is altered in amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol. 47:1988;642-653.
17. Munoz D.G., Greene C., Perl D.P., Selkoe D.J. Accumulation of phosphorylated neurofilaments in anterior horn motoneurons of amyotrophic lateral sclerosis patients. J. Neuropathol. Exp. Neurol. 47:1988;9-18.
18. Leigh P.N., Dodson A., Swash M., Brion J.-P., Anderton B.H. Cytoskeletal abnormalities in motor neuron disease. Brain. 112:1989;521-535.
19. Murayama S., Bouldin T.W., Suzuki K. Immunocytochemical and ultrastructural studies of upper motor neurons in amyotrophic lateral sclerosis. Acta Neuropathol. 83:1992;518-524.
20. Chou S.M. Motor neuron inclusions in ALS are heavily ubiquitinated. J. Neuropathol. Exp. Neurol. 47:1988;334.
21. Murayama S., Mori H., Ihara Y., Bouldin W., Suzuki K., Tomonaga M. Immunocytochemical and ultrastructural studies of lower motor neurons in amyotrophic lateral sclerosis. Ann. Neurol. 27:1990;137-148.
22. Leigh P., Swash M. Cytoskeletal pathology in motor neuron disease. Rowland L.P. Amyotrophic lateral sclerosis and other motor neuron diseases. Advances in neurology. 1991;115-124 Raven Press, New York.
23. Migheli A., Attanasio A., Schiffer D. Ubiquitin and neurofilament expression in anterior horn cells in amyotrophic lateral sclerosis: possible clues to the pathogenesis. Neuropathol. Appl. Neurobiol. 20:1994;282-289.
24. Chou S.M., Wang H.S., Komai K. Colocalization of NOS and SOD1 in neurofilament accumulation within motor neurons of amyotrophic lateral sclerosis: an immunohistochemical study. J. Chem. Neuroanat. 10:1996;249-258.
25. Abe K., Pan L.-H., Watanabe M., Kato T., Itoyama Y. Induction of nitrotyrosine-like immunoreactivity in the lower motor neuron of amyotrophic lateral sclerosis. Neurosci. Lett. 199:1996;152-154.
26. Abe K., Pan L.-H., Watanabe M., Konno H., Kato T., Itoyama Y. Upregulation of protein-tyrosine nitration in the anterior horn cells of amyotrophic lateral sclerosis. Neurol. Res. 1997;124-128.
27. Beal F.M., Ferrante R.J., Browne S.E., Matthews R.T., Kowall N.W., Brown R.H. Jr. Increased 3-nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis. Ann. Neurol. 42:1997;646-654.
28. Ferrante R.J., Shinobu L.A., Schulz J.B., Matthews R.T., Thomas C.E., Kowall N.W., Gurney M.E., Beal M.F. Increased 3-nitrotyrosine and oxidative damage in mice with a human copper/zinc superoxide dismutase mutation. Ann. Neurol. 42:1997;326-334.
29. Chou S.M. Neuropathology of amyotrophic lateral sclerosis: new perspectives on an old disease. J. Formos. Med. Assoc. 96:1997;488-498.
30. Ching G.Y., Liem R.K.H. Assembly of type IV neuronal intermediate filaments in nonneuronal cells in the absence of preexisting cytoplasmic intermediate filaments. J. Cell Biol. 122:1993;1323-1335.
31. Lee M.K., Xu Z., Wong P.C., Cleveland D.W. Neurofilaments are obligate heteropolymers in vivo. J. Cell Biol. 122:1993;1337-1350.
32. Leung C.L., Liem R.K.H. Characterization of interactions between the neurofilament triplet proteins by the yeast two-hybrid system. J. Biol. Chem. 271:1996;14041-14044.
33. 2 in the low-molecular-mass neurofilament subunit. J. Neurochem. 66:1996;1207-1213.
34. Streifel T.D., Avalos R.T., Cohlberg J.A. cAMP-dependent phosphorylation of neurofilament proteins NF-L and NF-M inhibits their coassembly into filaments in vitro. Biochem. Biophys. Res. Commun. 222:1996;646-651.
35. Heins S., Wong P.C., Muller S., Goldie K., Cleveland D.W., Aebi U. The rod domain of NF-L determines neurofilament architecture, whereas the end domains specify filament assembly and network formation. J. Cell Biol. 123:1993;1517-1533.
36. Hisanaga S., Gonda Y., Inagaki M., Ikai A., Hirokawa N. Effects of phosphorylation on neurofilament L protein on neurofilamentous structures. Cell Regul. 1:1990;237-248.
37. Nakamura Y., Takeda M., Angelides K.J., Tanaka T., Tada K., Nishimura T. Effect of phosphorylation on 68 kDa neurofilament subunit protein assembly by the cyclic AMP dependent protein kinase in vitro. Biochem. Biophys. Res. Commun. 169:1990;744-750.
38. Hisanaga S., Matsuoka Y., Nishizawa K., Saito T., Inagaki M., Hirokawa N. Phosphorylation of native and reassembled neurofilaments composed of NF-L, NF-M, and NF-H by the catalytic subunit of cAMP-dependent protein kinase. Mol. Biol. Cell. 5:1994;161-172.
39. Nixon R.A., Shea T.B. Dynamics of neuronal intermediate filaments: a developmental perspective. Cell Motil. Cytoskeleton. 22:1992;81-91.
40. Gill S.R., Wong P.C., Monteiro M.J., Cleveland D.W. Assembly properties of dominant and recessive mutations in the small mouse neurofilament (NF-L) subunit. J. Cell Biol. 111:1990;2005-2019.
41. Schmalbruch H., Jensen H.-J.S., Bjaerg M., Kamieniecka Z., Kurland L. A new mouse mutant with progressive motor neuronopathy. J. Neuropathol. Exp. Neurol. 50:1991;192-204.
42. Lee M.K., Marszalek J.R., Cleveland D.W. A mutant neurofilament subunit causes massive, selective motor neuron death: implications for the pathogenesis of human motor neuron disease. Neuron. 13:1994;975-988.
43. Nixon R.A., Sihag R.K. Neurofilament phosphorylation: a new look at regulation and function. TINS. 14:1991;501-506.
44. Elhanany E., Jaffe H., Link W.T., Sheeley D.M., Gainer H., Pant H.C. Identification of endogenously phosphorylated KSP sites in the high-molecular-weight rat neurofilament protein. J. Neurochem. 63:1994;2324-2335.
45. Gotow T., Tanaka J. Phosphorylation of neurofilament H subunit as related to arrangement of neurofilaments. J. Neurosci. Res. 37:1994;691-713.
46. Gotow T., Toshihisa T., Nakamura Y., Takeda M. Dephosphorylation of the largest neurofilament subunit protein influences the structure of crossbridges in reassembled neurofilaments. J. Cell Sci. 107:1994;1949-1957.
47. Pant H.C., Veeranna. Neurofilament phosphorylation. Biochem. Cell Biol. 73:1995;575-592.
48. Komiya Y., Tashiro T., Kurokawa M. Phosphorylation of neurofilament proteins during their axonal transport. Biomed. Res. 7:1986;345-348.
49. Oblinger M.M. Characterization of post translational processing of the mammalian high-molecular-weight neurofilament in vivo. J. Neurosci. 7:1987;2510-2521.
50. Shea T.B., Majocha R.E., Marotta C.A., Nixon R.A. Soluble, phosphorylated forms of the high molecular weight neurofilament protein in perikarya of cultured neuronal cells. Neurosci. Lett. 92:1988;291-297.
51. Julien J.-P., Mushynski W.E. Multiple phosphorylation sites in mammalian neurofilament polypeptides. J. Biol. Chem. 257:1982;10467-10470.
52. Geisler N., Kaufmann E., Fischer S., Plessman U., Weber K. Neurofilament architecture combines structural principles of intermediate filaments with carboxy-terminal extensions increasing in size between triplet proteins. EMBO. 2:1983;1295-1302.
53. Lee V.M.Y., Otvos L., Carden M.J., Hollosi M., Dietzschold B., Lazzarini R.A. Identification of the major multiphosphorylation site in mammalian neurofilaments. Proc. Natl. Acad. Sci. USA. 85:1988;1998-2002.
54. Hellmich M.R., Pant H.C., Wada E., Battey J.F. Neuronal cdc2-like kinase: a cdc2-related protein kinase with predominantly neuronal expression. Proc. Natl. Acad. Sci. USA. 89:1992;10867-10871.
55. Shetty K.T., Link W.T., Pant H.C. cdc2-like kinase from rat spinal cord specifically phosphorylates KSPXK motifs in neurofilament proteins: isolation and characterization. Proc. Natl. Acad. Sci. USA. 90:1993;6844-6848.
56. cdc2. J. Biol. Chem. 267:1992;25922-25926.
57. Lew J., Huang Q.-Q., Zhong Q., Winkfein R.J., Aebersold R., Hunt T., Wang J.H. A brain-specific activator of cyclin-dependent kinase 5. Nature. 371:1994;423-426.
58. Lew J., Qi Z., Huang Q.-Q., Paudel H., Matsuura I., Matsushita M., Zhu X., Wang J.H. Structure, function, and regulation of neuronal cdc2-like protein kinase. Neurobiol. Aging. 16:1995;263-270.
59. Geisler N., Weber K. Phosphorylation of desmin in vitro inhibits formation of intermediate filaments: identification of three kinase A sites on the amino-terminal head domain. EMBO. 7:1988;15-20.
60. Inagaki M., Gonda Y., Matsuyama M., Nishizawa K., Nishi Y., Sato C. Intermediate filament reconstitution in vitro. The role of phosphorylation on the assembly-disassembly of desmin. J. Biol. Chem. 263:1988;5970-5978.
61. Traub P., Vorgia C.E. Involvement of the N-terminal polypeptide of vimentin in the formation of intermediate filaments. J. Cell Sci. 65:1989;1-20.
62. Inagaki M., Nishi Y., Nishizawa K., Matsuyama M., Sato C. Site-specific phosphorylation induces disassembly of vimentin filaments in vitro. Nature. 328:1989;649-652.
63. Inagaki M., Gonda Y., Nishizawa K., Kitamura S., Sato C., Ando S., Tanabe K., Kikuchi K., Tsuiki S., Nishi Y. Phosphorylation sites linked to glial filament disassembly in vitro locate to a non-α-helical domain. J. Cell Biol. 265:1990;4722-4729.
64. Pleasure S.J., Lee V.M.Y., Nelson D.L. Site-specific phosphorylation of the middle molecular weight human neurofilament protein in transfected non-neuronal cells. J. Neurosci. 10:1990;2428-2437.
65. Gonda Y., Nishizawa K., Ando S., Kitamura S., Minoura Y., Nishi Y., Inagaki M. Involvement of protein kinase C in the regulation of assembly-disassembly of neurofilaments in vitro. Biochem. Biophys. Res. Commun. 167:1990;1316-1325.
66. Sihag R.K., Nixon R.A. Identification of Ser-55 as a major protein kinase A phosphorylation site on the 70-kDa subunit of neurofilaments. J. Biol. Chem. 266:1991;18861-18867.
67. Nixon R.A., Marotta C.A. Degradation of neurofilament proteins by purified human brain cathepsin D. J. Neurochem. 43:1984;507-516.
68. Malik M.N., Sheikh A.M., Fenko M.D., Wisniewski H.M. Purification and degradation of purified neurofilaments by the brain calcium-activated neutral proteases. Life Sci. 39:1986;1335-1343.
69. Banay-Schwartz M., Dahl D., Hui K.-S., Lajtha A. The breakdown of the individual neurofilament proteins by cathepsin D. Neurochem. Res. 12:1987;361-367.
70. Pant H.C. Dephosphorylation of neurofilament proteins enhances their susceptibility to degradation by calpain. Biochem. J. 256:1988;665-668.
71. Greenwood J.C., Troncoso J.C., Johnson G.V.W. Phosphorylation, calmodulin binding and calpain-mediated degradation of individual neurofilament proteins. Soc. Neurosci. Abstr. 17:1991;378. abstract.
72. Johnson G.V.W., Greenwood J.A., Costello A.C., Troncoso J.C. The regulatory role of calmodulin in the proteolysis of individual neurofilament proteins by calpain. Neurochem. Res. 16:1991;869-873.
73. Hisanaga S., Yasugawa S., Yamakawa T., Miyamoto E., Ikebe M., Uchiyama M., Kishimoto T. Dephosphorylation of microtubule-binding sites at the neurofilament-H tail domain by alkaline, acid, and protein phosphatases. J. Biochem. 113:1993;705-709.
74. Cunningham K., Sopper M.M., Strong M.J. Enhanced ex vivo cosedimentation of high molecular weight neurofilament protein (NFH) with microtubules following in vivo aluminum chloride exposure. Inhibition of dephosphorylation-dependent dissociation. NeuroToxicology. 18:1997;355-362.
75. Durham H.D. An antibody against hyperphosphorylated neurofilament proteins collapses the neurofilament network in motor neurons but not in dorsal root ganglion cells. J. Neuropathol. Exp. Neurol. 51:1992;287-297.
76. Strong M.J. Aluminum-induced neurodegeneration with special reference to amyotrophic lateral sclerosis and dialysis encephalopathy. Rev. Biochem. Toxicol. 11:1994;75-115.
77. Strong M.J., Mao K., Nerurkar V.R., Wakayama I., Yanagihara R., Garruto R.M. Dose-dependent selective suppression of light (NFL) and medium (NFM) but not high (NFH) molecular weight neurofilament gene transcription in acute aluminum neurotoxicity. Mol. Cell. Neurosci. 5:1994;319-326.
78. Wong J., Oblinger M.M. Changes in neurofilament gene expression occur after axotomy of dorsal root ganglion neurons: an in situ hybridization study. Metab. Brain Dis. 2:1987;291-303.
79. Hoffman P.N., Cleveland D.W. Neurofilament and tubulin expression recapitulates the developmental program during axonal regeneration: induction of a specific β-tubulin isotype. Proc. Natl. Acad. Sci. USA. 85:1988;4530-4533.
80. Hoffman P.N., Pollock S.C., Striph G.G. Altered gene expression after optic nerve transection: reduced neurofilament expression as a general response to axonal injury. Exp. Neurol. 119:1993;32-36.
81. Strong M.J., Gaytan-Garcia S. Proximal sciatic axotomy does not inhibit the induction of neurofilamentous inclusions following intracisternal aluminum chloride exposure. J. Neuropathol. Exp. Neurol. 55:1996;419-423.
82. Strong M.J., Gaytan-Garcia S. Sciatic motor neuron neurofilamentous inclusion formation following intracisternal aluminum chloride exposure in axotomized rabbits. Soc. Neurosci. Abstr. 20:1994;1662.
83. Strong M.J., Jakowec D.M. 200 kDa and 160 kDa neurofilament protein phosphatase resistance following in vivo aluminum chloride exposure. NeuroToxicology. 15:1994;799-808.
84. Savory J., Herman M.M., Hundley J.C., Seward R.L., Griggs C.M., Katsetos C.D., Wills M.R. Quantitative studies on aluminum deposition and its effects on neurofilament protein expression and phosphorylation, following intraventricular administration of aluminum maltolate to adult rabbits. NeuroToxicology. 14:1993;9-12.
85. Yamamoto H., Saitoh Y., Yasugawa S., Miyamoto E. Dephosphorylation of τ factor by protein phosphatase 2A in synaptosomal cytosol fractions, and inhibition by aluminum. J. Neurochem. 55:1990;683-690.
86. Shetty K.T., Veeranna, Guru S.C. Phosphatase activity against neurofilament proteins from bovine spinal cord: effect of aluminium and neuropsychoactive drugs. Neurosci. Lett. 137:1992;83-86.
87. Strong M.J., Wolff A.V., Wakayama I., Garruto R.M. Aluminum-induced chronic myelopathy in rabbits. NeuroToxicology. 12:1991;9-22.
88. Wakayama I., Nerurkar V.R., Strong M.J., Garruto R.M. Comparative study of chronic aluminum-induced neurofilamentous aggregates with intracytoplasmic inclusions of amyotrophic lateral sclerosis. Acta Neuropathol. 92:1996;545-554.
89. Gaytan-Garcia S., Kim H., Strong M.J. Spinal motor neuroaxonal spheroids in chronic aluminum neurotoxicity contain phosphatase-resistant high molecular weight neurofilament (NFH). Toxicology. 108:1996;17-24.
90. Côte F., Collard J.-F., Julien J.-P. Progressive neuronopathy in transgenic mice expressing the human neurofilament heavy gene: a mouse model of amyotrophic lateral sclerosis. Cell. 73:1993;35-46.
91. Xu Z., Cork L.C., Griffin J.W., Cleveland D.W. Increased expression of neurofilament subunit NF-L produces morphological alterations that resemble the pathology of human motor neuron disease. Cell. 73:1993;23-33.
92. Julien J.-P., Côté F., Collard J.-F. Mice overexpressing the human neurofilament heavy gene as a model of ALS. Neurobiol. Aging. 16:1995;487-492.
93. Collard J.-F., Côté F., Julien J.-P. Defective axonal transport in a transgenic mouse model of amyotrophic lateral sclerosis. Nature. 375:1995;61-64.
94. Zhu Q., Couillard-Després S., Julien J.-P. Delayed maturation of regenerating myelinated axons in mice lacking neurofilaments. Exp. Neurol. 148:1997;299-316.
95. Tu P.-H., Raju P., Robinson K.A., Gurney M.E., Trojanowski J.Q., Lee V.M.Y. Transgenic mice carrying a human mutant superoxide dismutase transgene develop neuronal cytoskeletal pathology resembling human amyotrophic lateral sclerosis lesions. Proc. Natl. Acad. Sci. USA. 93:1996;3155-3160.
96. Dal Canto M.C., Gurney M.E. A low expressor line of transgenic mice carrying a mutant human Cu,Zn superoxide dismutase (SOD1) gene develops pathological changes that most clearly resemble those in human amyotrophic lateral sclerosis. Acta Neuropathol. 93:1997;537-550.
97. Carter J.E., Gallo J.-M., Anderson V.E.R., Anderton B.H., Robertson J. Aggregation of neurofilaments in NF-L transfected neuronal cells: regeneration of the filamentous network by a protein kinase C inhibitor. J. Neurochem. 67:1996;1997-2004.
98. Figlewicz D.A., Krizus A., Martinoli M.G., Meininger V., Dib M., Rouleau G.A., Julien J.-P. Variants of the heavy neurofilament subunit are associated with the development of amyotrophic lateral sclerosis. Hum. Mol. Genet. 3:1994;1757-1761.
99. Yamasaki H., Itakura C., Mizutani M. Hereditary hypotrophic axonopathy with neurofilament deficiency in a mutant strain of the Japanese quail. Acta Neuropathol. 82:1991;427-434.
100. Zhao J.X., Ohnishi A., Itakura C., Mizutani M., Yamamoto T., Hojo T., Murai Y. Smaller axon and unaltered numbers of microtubules per axon in relation to number of myelin lamellae of myelinated fibers in the mutant quail deficient in neurofilaments. Acta Neuropathol. 89:1995;305-312.
101. Eyer J., Cleveland D.W., Wong P.C., Peterson A.C. Pathogenesis of two axonopathies does not require axonal neurofilaments. Nature. 391:1998;584-587.
102. Bergeron C., Beric-Maskarel K., Muntasser S., Weyer L., Somerville M., Percy M.E. Neurofilament light and polyadenylated mRNA levels are decreased in amyotrophic lateral sclerosis motor neurons. J. Neuropathol. Exp. Neurol. 53:1994;221-230.
103. Wong N., He B., Strong M.J. Altered stoichiometric ratio of steady state neurofilament mRNA levels in amyotrophic lateral sclerosis. Mol Cell Biol. 9:(suppl):1998;159.
104. Rosen D.R., Siddique T., Patterson D., Figlewicz D.A., Sapp P., Hentati A., Donaldson D., Goto J., O'Regan J.P., Deng H.-X., Rahmani Z., Krizus A., McKenna-Yasek D., Cayabyab A., Gaston S.M., Berger R., Tanzi R.E., Halperin J.J., Herzfeldt B., Van den Bergh R., Hung W.-Y., Bird T., Deng G., Mulder D.W., Syth C., Laing N.G., Soriano E., Pericak-Vance M.A., Haines J., Rouleau G.A., Gusella J.S., Horvitz H.R., Brown R.H. Jr. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 362:1993;59-62.
105. Beckman J.S., Carson M., Smith C.D., Koppenol W.H. ALS, SOD and peroxynitrite. Science. 364:1993;584.
106. Bruijn L.I., Houseweart M.K., Kato S., Anderson K.L., Anderson S.D., Ohama E., Reaume A.G., Scott R.W., Cleveland D.W. Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1. Science. 281:1998;1851-1854.
107. Wiedau-Pazos M., Goto J.J., Rabizadeh S., Gralla E.B., Roe J.A., Lee M.K., Valentine J.S., Bredesen D.E. Altered reactivity of superoxide dismutase in familial amyotrophic lateral sclerosis. Science. 271:1996;515-518.
108. Chou S.M., Wang H.S., Taniguchi A. Role of SOD-1 and nitric oxide/cyclic GMP cascade on neurofilament aggregation in ALS/MND. J. Neurol. Sci. 139:1996;16-26.
109. Crow J.P., Ye Y.Z., Strong M.J., Kirk M., Barnes S., Beckman J.S. Superoxide dismutase catalyzes nitration of tyrosines by peroxynitrite in the rod and head domains of neurofilament-L. J. Neurochem. 69:1997;1945-1953.
110. Strong M.J., Sopper M.M., Crow J.P., Strong W.L., Beckman J.S. Nitration of the low molecular weight neurofilament (NFL) is equivalent in sporadic amyotrophic lateral sclerosis and control cervical spinal cord. Biochem. Biophys. Res. Commun. 248:1998;157-164.
111. Bowling A.C., Schulz J.B., Brown R.H. Jr., Beal M.F. Superoxide dismutase activity, oxidative damage, and mitochondrial energy metabolism in familial and sporadic amyotrophic lateral sclerosis. J. Neurochem. 61:1993;2322-2325.
112. Przedborksi S., Donaldson D., Jakowec M., Kish S.J., Guttman M., Rosoklija G., Hays A.P. Brain superoxide dismutase, catalase, and glutathione peroxidase activities in amyotrophic lateral sclerosis. Ann. Neurol. 39:1996;158-165.
113. Chou S.M., Wang H.S., Taniguchi A., Bucala R. Advanced glycation endproducts in neurofilament conglomeration of motoneurons in familial and sporadic amyotrophic lateral sclerosis. Mol. Med. 4:1998;324-332.
114. Wong N., Strong M.J. Nitric oxide synthase expression in cervical motor neurons of sporadic amyotrophic lateral sclerosis. Eur J Cell Biol. 77:1998;338-343.
115. Kawamata T., Akiyama H., Yamada T., McGeer P.L. Immunological reactions in amyotrophic lateral sclerosis brain and spinal cord tissue. Am. J. Pathol. 140:1992;691-707.
116. Dinerman J.L., Steiner J.P., Dawson T.M., Dawson V., Snyder S.H. Cyclic nucleotide dependent phosphorylation of neuronal nitric oxide synthase inhibits catalytic activity. Neuropharmacology. 33:1994;1245-1251.
117. Dawson V.L., Dawson T.M. Nitric oxide in neuronal degeneration. Proc. Soc. Exp. Biol. Med. 211:1996;33-40.
118. Griffin J., Cork L.C., Troncoso J.C., Price D.L. Experimental neurotoxic disorders of motor neurons: neurofibrillary pathology. Rowland L.P. Human motor neuron diseases. 1982;419-433 Raven Press, New York.
119. Strong M.J., Garruto R.M. Experimental paradigms of motor neuron degeneration. Woodruff M.L., Nonneman A. Animal models of toxin-induced neurological disorders. 1994;39-88 Plenum Press, New York.